Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals-Reference-Cited by-同舟云学术

Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals

Published:2017-12 Issue: Volume:313 Page:16-24
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Krestova Michala^ORCID,Hromadkova Lenka^ORCID,Bilkova Zuzana,Bartos Ales,Ricny Jan

Funder

MEYS

Czech Science Foundation

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference59 articles.

1. Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity;d'Abramo;PLoS One,2013

2. Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain;Arai;J. Neuropathol. Exp. Neurol.,2006

3. Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta;Balakrishnan;J. Alzheimers Dis.,2010

4. Novelizace české verze Addenbrookského kognitivního testu (ACE-CZ);Bartoš;Cesk Slov Neurol N,2011

5. Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament;Bartos;J. Neuroimmunol.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis;Antibodies;2023-12-08

2. Efficacy and safety of blood derivatives therapy in Alzheimer’s disease: a systematic review and meta-analysis;Systematic Reviews;2022-11-29

3. Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases;Theranostics;2022

4. Large-scale seroepidemiology identifies a nephro-vascular syndrome associated with autoimmune reactivity to tau;2021-11-26

5. Tau Protein-Targeted Therapies in Alzheimer’s Disease: Current State and Future Perspectives;Alzheimer’s Disease: Drug Discovery;2020-12-18